The Heterogeneity of Glioma Stem Cells

Author(s): Suojun Zhang, Feng Wan, Lin Han, Fei Ye, Dongsheng Guo, Ting Lei

Journal Name: Current Signal Transduction Therapy

Volume 9 , Issue 2 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Glioblastoma, a highly lethal brain tumor, features extensive heterogeneity at the cellular and molecular levels. The discovery of glioma stem cells (GSCs) supports a new paradigm in tumor biology and therapeutic targeting. GSCs contribute to the cellular origin of primary gliomas and the recurrence of malignant gliomas after traditional treatments. A growing body of evidence suggests that GSCs, just as the bulk tumor cells, are heterogeneous with phenotypic and genetic complexity. Heterogeneous GSCs may add to glioblastoma heterogeneity and impact response to current therapies. A better understanding of GSC heterogeneity is required to facilitate the design of more effective therapies against this highly malignant brain tumor.

Keywords: Glioblastoma, glioma stem cells, heterogeneity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 12 February, 2015
Page: [70 - 77]
Pages: 8
DOI: 10.2174/1574362409666140901225437
Price: $65

Article Metrics

PDF: 56